FDA product code NVO: Spacer, Direct Patient Interface

NVO is the FDA product code for spacer, direct patient interface. It is a Class II device, regulated under 21 CFR 868.5630 and reviewed by the Anesthesiology panel. FDA has cleared 2 510(k) submissions under NVO. The average 510(k) review took 120 days (median 120).

Definition

Spacers are devices that are used with nebulizers and metered dose inhalers that are comprised of a reservior into which an aerosol medication is dispensed. A spacer uses an open mouthpiece. Spacers are intended to minimize delivery of large aerosolized particles.

Classification

FieldValue
Device nameSpacer, Direct Patient Interface
Device classClass II
Regulation21 CFR 868.5630
Review panelAN — Anesthesiology
Medical specialtyAnesthesiology
Premarket route510(k)

Top NVO applicants

ApplicantClearancesLatest
Pharmacaribe22010-09-01

Most recent NVO clearances

510(k)ApplicantDeviceDecision dateReview days
K101532PharmacaribeNESSI OTC SPACER2010-09-0190
K091862PharmacaribeNESSI SPACER2009-11-20150

Recalls for NVO devices

openFDA lists no recalls for product code NVO.

HCPCS codes with matching descriptors

Text match between the FDA device name and CMS descriptors, not an official crosswalk:

Frequently asked questions

What is FDA product code NVO?

NVO is the FDA product code for spacer, direct patient interface. It is a Class II device, regulated under 21 CFR 868.5630 and reviewed by the Anesthesiology panel.

What device class is NVO?

Class II, regulation 21 CFR 868.5630. Typical premarket route: 510(k).

How long does a 510(k) take for product code NVO?

Across 2 cleared submissions the average was 120 days from receipt to decision (median 120).

Which companies have the most NVO clearances?

Pharmacaribe (2).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Anesthesiology product codes · FDA product code lookup